Literature DB >> 12572718

Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital.

A Chakrabarti1, S Sethi, D S V Raman, D Behera.   

Abstract

A total of 651 patients with clinically suspected allergic bronchopulmonary aspergillosis (ABPA) were evaluated during the 8-year period from January 1991 to December 1998. Overall, 338 cases (51.9%) were positive either by sputum microscopy/culture (66 of 203 patients), by skin reactivity (150 of 309 cases), or by precipitating antibodies (122 of 338 patients) against Aspergillus species. However, in 89 patients, diagnosis of ABPA was confirmed on the basis of Rosenberg's criteria. Clinical profile and laboratory findings of those patients were analysed. The disease was found to be more common among males. Poor control of asthma, constitutional symptoms, mucopurulent expectoration, increased dyspnoea and wheezing and rhonchi were the main presenting features. Skin reactivity against aspergillin was seen in 73 (82%), precipitating antibodies against Aspergillus species were positive in 64 (72%) and sputum microscopy/culture was positive in 56 (63%) of those 89 patients. Central bronchiectasis and fleeting shadows were the most common radiological findings. This study highlights the importance of ABPA in north India and draws attention to the need for further analysis of criteria to use in the diagnosis of patients with ABPA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12572718     DOI: 10.1046/j.1439-0507.2002.00738.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  20 in total

Review 1.  Severe asthma with fungal sensitization.

Authors:  Ritesh Agarwal
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

Review 2.  The potential hazards of Aspergillus sp. in foods and feeds, and the role of biological treatment: a review.

Authors:  Sheikh Imranudin Sheikh-Ali; Akil Ahmad; Siti-Hamidah Mohd-Setapar; Zainul Akmal Zakaria; Norfahana Abdul-Talib; Aidee Kamal Khamis; Md Enamul Hoque
Journal:  J Microbiol       Date:  2014-10-01       Impact factor: 3.422

3.  Allergic bronchopulmonary candidiasis.

Authors:  Vasu Vardhan; Deepak S Mulajker
Journal:  Med J Armed Forces India       Date:  2012-08-14

4.  Youngest Case of Allergic Broncho Pulmonary Aspergillosis in India: A Case Report from Arid Zone of India.

Authors:  Navgeet Mathur; Medha Mathur; Virendra Singh
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 5.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

6.  Allergic bronchopulmonary aspergillosis: A review of 42 patients from a tertiary care center in India.

Authors:  R Prasad; R Garg; A D Shukla
Journal:  Lung India       Date:  2009-04

7.  ABPA Concomitantly Occurring with Invasive Sinus Aspergillosis: A Short Report on Two Patients.

Authors:  Satyawati Mohindra; Roopa Mehta; Amanjit Bal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-09-04

8.  High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.

Authors:  David W Denning; Steven Park; Cornelia Lass-Florl; Marcin G Fraczek; Marie Kirwan; Robin Gore; Jaclyn Smith; Ahmed Bueid; Caroline B Moore; Paul Bowyer; David S Perlin
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

9.  Misinterpretation of allergic bronchopulmonary aspergillosis/allergic bronchopulmonary mycosis due to diverse characteristics in different clinical stages.

Authors:  Haijun Feng; Ping Lv; Xiaoxia Ren; Huaping Dai; Ting Yang
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

10.  Insights into fungal communities in composts revealed by 454-pyrosequencing: implications for human health and safety.

Authors:  Vidya De Gannes; Gaius Eudoxie; William J Hickey
Journal:  Front Microbiol       Date:  2013-06-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.